Panel recommends granting permission to Dr Reddy’s for phase 2 trials of Russian COVID vaccine

  • by
The Hyderabad-based pharmaceutical firm had on October 13 reapplied to the Drugs Controller General of India (DCGI) seeking permission to conduct combined phase 2 and 3 human clinical trials of the vaccine in the country.